• Bactiquant raised its 2026 EBITDA forecast to a loss of DKK 6 million–7 million from a loss of DKK 7 million–10 million.
• Revenue guidance narrowed to DKK 10 million–11 million from DKK 10 million–13 million.
• Expected revenue of slightly above DKK 10 million represents growth of at least 20% from 2025.
• The narrower revenue range reflects greater clarity on delivery timing for orders around year-end.
• Significant cost reductions disclosed on August 11, 2026, are driving the improved EBITDA outlook.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bactiquant A/S published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.